Thorne continues to focus on empowering individuals to live healthier longer through personalized, scientific testing and solutions. 

Join us for an exclusive 2-day event in sunny South Carolina. Listen and interact with sector experts in science, medicine, business, sports performance, finance, and journalism who will present their insights on emerging research, technological advancements, and clinical outcomes within the context of sport and our society. 

Please send interest to ThorneSummit@thorne.com if you want to attend without accommodations at the Wild Dunes Resort.

Event Details

Where: Wild Dunes Resort, Isle of Palms, South Carolina. Registration includes two nights at the resort.

Who is attending: There is limited, first-come, first-serve registration available to 125 attendees. We have geared the summit’s topics and speakers to attract Thorne’s growing health-care professional network, top-tier athletic community, and biohacking population. Thorne encourages anyone interested in optimizing the human health span to join us. Registration is open to practitioners, researchers, athletes, health enthusiasts, and media/public relations from around the world who have a passion for healthy aging through the lifespan to meet at this intimate, inaugural event.

Who is speaking: Our world-class lineup of scientists and medical experts, among others, will present individually and participate in Q&A panel discussions on topics in their fields:

George Church, PhD, Professor, Harvard Medical School and MIT

George Church received his PhD from Harvard in 1984, is co-author of 625 papers, has 156 patent publications, and has written a book, Regenesis. Dr. Church developed methods used for the first genome sequence (1994) and 10 million-fold cost reductions since (via fluor-NGS and nanopores), multiplexing/barcoding, DNA assembly from chips, and genome editing/writing/recoding. Dr. Church co-initiated BRAIN Initiative (2011) and Genome Projects (GP-Read-1984, GP-Write-2016, PGP-2005:world's open-access personal precision medicine datasets); machine learning for protein engineering, tissue reprogramming, organoids, xeno-transplantation, in situ 3-D DNA, RNA, and protein imaging.

David Dodick, MD, Chief Science Officer, Atria; Physician and Professor, Mayo Clinic

David Dodick, MD, FAAN, is professor emeritus at Mayo Clinic and a consultant for Mayo Clinic International. He is also chief science officer and chair for Atria Academy of Science and Medicine. He is an adjunct professor in the Department of Neurosciences, Norwegian University of Science and Technology. Dr. Dodick is board certified by the Royal College of Physicians and Surgeons of Canada and the American Board of Psychiatry and Neurology (ABPN). He also holds United Council for Neurologic Subspecialties certification in headache medicine and ABPN certification in vascular neurology. Dr. Dodick has authored more than 380 peer-reviewed publications and authored/edited 10 books. He is the chair of the American Migraine Foundation, American Academy of Neurology (AAN) Annual Program Concussion Committee; co-director of the American Registry of Migraine Research; chair of International Registry for Migraine Research; chair of International Headache Society Global Patient Advocacy Coalition; co-director of the Annual AAN Sports Concussion Conference; president-elect of the International Concussion Society; immediate past-president of the International Headache Society; former editor-in-chief of Cephalalgia; and past-president of the American Headache Society.

Joel Dudley, PhD, Partner at Innovation Endeavors; Scientific Advisor, Thorne HealthTech 

Joel Dudley, PhD, is a partner at Innovation Endeavors and scientific advisor for Thorne HealthTech. He has served as chief scientific officer at Tempus since 2020. Dr. Dudley was an associate professor of Genetics and Genomic Sciences and founding director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai Hospital. He also served as executive vice president for Precision Health for the Mount Sinai Health System. Prior to Mount Sinai, he held positions as co-founder of NuMedii, Inc., developing machine learning technologies for drug discovery, and consulting professor of Systems Medicine in the Department of Pediatrics at Stanford University School of Medicine. His more than 200 peer-reviewed research publications established novel precision medicine paradigms at the nexus of -omics, digital health, artificial intelligence (AI), scientific wellness, and health-care delivery. His work has been featured in The New York Times, The Wall Street Journal, Scientific American, MIT Technology Review, CNBC, and other popular media outlets. He was named in 2014 as one of the 100 most creative people in business by Fast Company magazine. He is co-author of the book Exploring Personal Genomics from Oxford University Press. Dudley received a BS in Microbiology from Arizona State University and an MS and PhD in Biomedical Informatics from Stanford University School of Medicine.

Vadim Gladyshev, PhD, Professor, Brigham and Women’s Hospital, Harvard Medical School

Vadim Gladyshev, PhD, is a professor of medicine at Brigham and Women's Hospital, Harvard Medical School, who specializes in antioxidant biology. He is known for his characterization of the human selenoproteome. Dr. Gladyshev has conducted studies on whether organisms can acquire cellular damage from their food and the role selenium plays as a micronutrient with significant health benefits. In 2013, he won the NIH Pioneer Award.

Sara Gottfried, MD, Physician and New York Times Best-Selling Author

Sara Gottfried, MD, is a board-certified gynecologist and physician-scientist. She is a global keynote speaker who practices evidence-based integrative, precision, and functional medicine. Her three New York Times best-selling books include The Hormone Cure, The Hormone Reset Diet, and Younger.

Lee Hood, MD, PhD, Chief Executive Officer, Phenome Health; Co-Founder and Chief Strategy Officer, Institute for Systems Biology

A world-renowned scientist and recipient of the National Medal of Science in 2011, Dr. Lee Hood co-founded the Institute for Systems Biology (ISB) in 2000 and served as its first president from 2000 to 2017. In 2016, ISB affiliated with Providence St. Joseph Health (PSJH) and Hood became PSJH’s senior vice president and chief science officer. He is also chief strategy officer and professor at ISB.

Dr. Hood is a member of the National Academy of Sciences, the National Academy of Engineering, and the National Academy of Medicine. Of the more than 6,000 scientists worldwide who belong to one or more of these academies, Hood is one of only 20 people who has been elected to all three.

Dr. Hood received his MD from Johns Hopkins University School of Medicine and his PhD in biochemistry from the California Institute of Technology. He was a faculty member at Caltech from 1967-1992, serving for 10 years as the chair of biology. During this period, he and his colleagues developed four sequencer and synthesizer instruments that paved the way for the Human Genome Project’s successful mapping and understanding of the human genome. He and his students deciphered many of the complex mechanisms of antibody diversification. In 1992, Dr. Hood founded and chaired the Department of Molecular Biotechnology at the University of Washington, the first academic department devoted to cross-disciplinary biology.

Dr. Hood has co-founded 17 biotech companies, including Amgen, Applied Biosystems, Rosetta, and Arivale. His many national and international awards include the Lasker Prize, the Kyoto Prize, and the National Medal of Science. Currently, he is the chief executive officer of Phenome Health and co-founder and professor at the Institute of Systems Biology in Seattle. 

Mahtab Jafari, PharmD, Professor, University of California, Irvine; Director, The UCI Center for Healthspan Sciences

Mahtab Jafari is professor of Pharmaceutical Sciences and the founding director of The UCI Center for Healthspan Sciences. She completed her residency at the University of California, San Francisco. She is also a National Board Certified Health and Wellness Coach. With 28 years of experience in academic and private settings, her research has focused on evaluating natural compounds and dietary supplements that extend lifespan and improve healthspan through a science that she introduced as “Healthspan Pharmacology.” Using Drosophila as her model system, she is now developing a multi-omics platform for natural products drug discovery. She is the author of the award-winning book The Truth About Dietary Supplements: An Evidence-Based Guide to a Safe Medicine Cabinet.

Suzanne Steinbaum, MD, Chief Executive Officer / Founder at Heart-Tech Health, Private Practice Preventive Cardiologist

Suzanne Steinbaum, MD, is a leader in preventive cardiology, now in private practice in New York City. She is the founder and chief executive officer of Heart-Tech Health, a med-tech innovation to decrease the risk of women’s cardiovascular disease and bring prevention to every woman regardless of location or circumstance. Dr. Steinbaum launched heart prevention programs at Mount Sinai Heart, Northwell Lenox Hill, and Beth Israel. She published Dr. Suzanne Steinbaum’s Heart Book: Every Woman’s Guide to a Heart-Healthy Life, has been a national spokesperson for Go Red through the American Heart Association for 18 years, serves on the national medical advisory board for Peloton, and is a frequent guest on notable shows like The Today Show, Good Morning America, The Dr. Oz Show, The Doctors, and more.

 #ThorneSummit